1. Home
  2. NTRA vs NTRS Comparison

NTRA vs NTRS Comparison

Compare NTRA & NTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • NTRS
  • Stock Information
  • Founded
  • NTRA 2003
  • NTRS 1889
  • Country
  • NTRA United States
  • NTRS United States
  • Employees
  • NTRA N/A
  • NTRS N/A
  • Industry
  • NTRA Medical Specialities
  • NTRS Major Banks
  • Sector
  • NTRA Health Care
  • NTRS Finance
  • Exchange
  • NTRA Nasdaq
  • NTRS Nasdaq
  • Market Cap
  • NTRA 22.1B
  • NTRS 21.4B
  • IPO Year
  • NTRA 2015
  • NTRS N/A
  • Fundamental
  • Price
  • NTRA $167.46
  • NTRS $107.75
  • Analyst Decision
  • NTRA Strong Buy
  • NTRS Hold
  • Analyst Count
  • NTRA 16
  • NTRS 12
  • Target Price
  • NTRA $160.63
  • NTRS $107.17
  • AVG Volume (30 Days)
  • NTRA 1.2M
  • NTRS 1.1M
  • Earning Date
  • NTRA 02-26-2025
  • NTRS 01-23-2025
  • Dividend Yield
  • NTRA N/A
  • NTRS 2.79%
  • EPS Growth
  • NTRA N/A
  • NTRS 51.89
  • EPS
  • NTRA N/A
  • NTRS 8.00
  • Revenue
  • NTRA $1,531,955,000.00
  • NTRS $7,857,600,000.00
  • Revenue This Year
  • NTRA $54.35
  • NTRS N/A
  • Revenue Next Year
  • NTRA $10.17
  • NTRS $3.83
  • P/E Ratio
  • NTRA N/A
  • NTRS $13.43
  • Revenue Growth
  • NTRA 54.94
  • NTRS 16.78
  • 52 Week Low
  • NTRA $62.96
  • NTRS $76.67
  • 52 Week High
  • NTRA $183.00
  • NTRS $111.87
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 52.44
  • NTRS 62.35
  • Support Level
  • NTRA $163.42
  • NTRS $98.42
  • Resistance Level
  • NTRA $174.15
  • NTRS $104.72
  • Average True Range (ATR)
  • NTRA 8.16
  • NTRS 1.78
  • MACD
  • NTRA -0.75
  • NTRS 0.70
  • Stochastic Oscillator
  • NTRA 44.26
  • NTRS 97.44

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About NTRS Northern Trust Corporation

Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of Dec. 31, 2023, Northern Trust had assets under custody or administration of $15.4 trillion and assets under management of $1.4 trillion.

Share on Social Networks: